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Abstract
Background: Aim of this study was to elucidate the relation between localised inflammatory heart
disease and endothelial dysfunction in the peripheral circulation, considering circulating cytokines
as a potential link.
Methods: In 38 patients with non-ischemic heart disease, myocardial biopsies were examined for
myocardial inflammation (immunohistology) and virus persistence (PCR). Cytokines (sIL-4, IFN-g,
IFN-b, IFN-a, sIL-12p7, TNF-a) were measured by ELISA in venous serum. Endothelial function of
the radial artery was examined by ultrasound, measuring diameter changes in response to reactive
hyperemia (FMD), compared to glyceroltrinitrate (GTN-MD). Patients with EF < 35% were
excluded.
Results: Age 44 ± 14 years, 19 male, 19 female, EF 63.5[16]%. FMD 4.38 [4.82]%. 30 patients had
myocardial inflammation (8 not), 23 virus persistence (15 not). FMD correlated significantly with
sIL-12p7 (p = 0.024, r = -0.365), but not with other cytokines. sIL-12p7 levels were significantly
higher in patients with severely impaired FMD (n = 17), compared with normal FMD (n = 21): 10.70
[10.72] vs. 4.33 [7.81] pg/ml (p = 0.002). Endothelium independent vasodilation (GTN-MD 23.67
[8.21]%) was not impaired.
Conclusion:  Endothelial dysfunction of peripheral arteries in patients with non-ischemic
cardiomyopathy is associated with elevated serum concentrations of sIL-12p7, but not of other
cytokines. Circulating sIL-12p7 may partly explain, that endothelial dysfunction is not restricted to
the coronary circulation, but involves systemic arteries.
Background
Endothelial dysfunction in patients with non-ischemic
heart disease, which has been observed in the coronary
circulation [1] as well as in systemic arteries [2,3], is asso-
ciated with myocardial inflammatory immune responses.
Other groups have demonstrated endothelial dysfunction
in systemic infections, like after thyphoid vaccination [4],
Kawasaki disease [5], in systemic vasculitis [6] and in
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association with elevated CRP-levels [7]. In the Framing-
ham Offspring Study with 2701 patients, an association
between systemic inflammation and endothelial dysfunc-
tion was confirmed [8]. Endothelial dysfunction may
determine prognosis, as has been demonstrated for
patients with atherosclerosis [9-11] and after transplanta-
tion [12]. Non-invasive measurement of endothelial dys-
function is preferred to invasive measurements. However,
the link between peripheral endothelial dysfunction and
non-ischemic heart disease, needs to be determined.
Inflammatory parameters have been associated with an
increased risk of cardiovascular events [13,14] or the pro-
gression of heart failure [15], similar to the observations
for endothelial function. Therefore, we consider circulat-
ing cytokines a potential link between non-ischemic heart
disease and peripheral endothelial dysfunction. Heart
failure itself is associated with endothelial dysfunction
[16-19] as well as with changes in the pattern of circulat-
ing cytokines [20,21], however endothelial dysfunction of
peripheral arteries is also observed in patients with non-
ischemic heart disease and only mildly or regionally
impaired left ventricular function. The aim of this study
was to elucidate the relation between non-ischemic heart
disease (in the absence of heart failure) and endothelial
dysfunction in the peripheral circulation, considering cir-
culating cytokines potential candidates for a link.
Methods
We included 38 patients with non-ischemic heart disease,
considering history, physical examination and non-inva-
sive tests, that were referred to our hospital for acquisition
and examination of myocardial biopsies. Inclusion crite-
ria were 1. suspected cardiomyopathy by history and
symptoms (chest pain, dyspnea, palpitations, exercise
intolerance) or by history and ECG-changes (ST-/T-devia-
tions, rhythm disturbances) and 2. echocardiographic
regional wall motion abnormalities or global left ven-
tricular dysfunction. Duration of symptoms was at least 3
months. By left ventricular catheterization and angiogra-
phy, coronary artery disease was excluded, left ventricular
ejection fraction and pressures were measured. Right-ven-
tricular catheterization was performed to obtain endomy-
ocardial biopsies and perform hemodynamic
measurements. To minimize other confounding factors
on endothelial dysfunction, patients with coronary artery
disease [9-11], diabetes [22], more than one other risk fac-
tor for arteriosclerosis [22-24], overt arteriosclerosis or
other severe disease were excluded from this study. As
heart failure is known to affect endothelial function [16-
19] as well as cytokine levels [20,21], we excluded patients
with an ejection fraction <35%. At the time of the study,
the majority of patients was already on cardiovascular
medication [19], which was ceased according to half-life
prior to the study, though this may not be necessary [25].
Sinus rhythm was required. The patients did not receive
any immunomodulatory therapies.
Informed consent was obtained from all patients.
Endothelial function
Endothelial function of the radial artery was measured, as
published previously [2,3]. By high resolution ultra-
sound, diameter changes in response to reactive hypere-
mia (FMD), compared to glyceroltrinitrate (GTN-MD),
were detected, referring to the standard protocols [26-28].
Flow mediated vasodilation in response to reactive hyper-
emia (FMD) represents endothelium dependent vasoreac-
tivity, whereas vasodilation in response to
glyceroltrinitrate (GTN-MD) indicates endothelium inde-
pendent smooth muscle cell function.
Calculations
FMD represents the percentage of diameter increase
caused by shear stress, compared to baseline. GTN-MD
represents the percentage of diameter increase induced by
GTN, compared to baseline.
Cytokine measurements
Venous blood samples were obtained from the cubital
vein from each patient by standard venous puncture. Sam-
ples were immediately centrifuged and the serum stored at
-80°C. Cytokine measurements (sIL-4, IFN-g, IFN-b, IFN-
a, sIL-12p7 and TNF-a) were performed with standard
sandwich enzyme immunoassay (ELISA) kits according to
the manufacturer's instructions: Hölzel Diagnostica Han-
dels GmbH Pelikine Compact TM human IFN ELISA kits
(sensitivity 1pg/ml), Hölzel Diagnostica Handels GmbH
Pelikine Compact TM human IL-4 ELISA kit (sensitivity
0.2 pg/ml), Genzyme Diagnostics PredictaHuman Total
Interleukin 12 ELISA kit (sensitivity 10 pg/ml).
Myocardial biopsies
Endomyocardial biopsies from the right ventricular sep-
tum were obtained by standard percutaneous transvenous
femoral approach with a standard bioptome.
Immunohistology
For immunohistological evaluation, the samples were
prepared and evaluated as published previously [1-
3,29,30]. Immunohistologically stained leucocytes
(CD2+, CD3+, CD4+, CD8+ and activated CD45RO+
lymphocytes, macrophages) were counted per high-power
field (400-fold magnification, equivalent to 0.28 mm2).
Endothelial expression of HLA-1, HLA-DR and ICAM-1
was scaled (1,2,3), according to intensity of immunoper-
oxidase staining. Myocardial inflammation was con-
firmed in myocardial biopsies, if more than 7 CD3+
lymphocytes per 1 mm2 tissue were identified and/or if
endothelial expression of cell adhesion molecules wasCardiovascular Ultrasound 2007, 5:49 http://www.cardiovascularultrasound.com/content/5/1/49
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enhanced. Myocardial biopsies were examined and ana-
lyzed by two independent blinded observers.
Statistical analysis
Statistical analysis was performed with the SPSS Inc. (Chi-
cago, Illinois) software, version 12.0 for IBM-PC. Descrip-
tive data are expressed as median and interquartile range.
Quantitative data were compared to qualitative data by
use of the Kruskal-Wallis test on rank sums for independ-
ent samples, followed by a post hoc multiple comparison
procedure, if appropriate. To compare quantitative data of
two groups, the Mann Whitney U test was applied. Quan-
titative data were correlated by use of the Spearman p
rank-order analysis, calculating the coefficient of correla-
tion r. Statistical significance was inferred at p < 0.05.
Results
Patients characteristics
General characteristics
Mean age of the 38 patients was 44.5518 years, 19 were
male, 19 female. At the time of investigation, all patients
were normotensive (9 treated for hypertension) and had
normal lipid-levels (8 treated with statins), 4 were smok-
ers. Of the patients on standard cardiovascular medica-
tion, 11 were treated with ACE-inhibitors, 1 with AT1-
antagonists, 9 with betablockers, 2 with calciumantago-
nists and 5 with digitalis glucosides.
Clinical presentation and history
29 patients presented with chest pain (angina), 12 with
palpitations, 34 with fatigue or exercise intolerance. At the
time of inclusion in the study, all patients were in NYHA-
stage I–II.
Non-invasive examinations
ST-segment or T-wave changes were documented in the
ECGs of 11 patients, rhythm disturbances in 9 patients.
Echocardiography revealed regional wall motion abnor-
malities or an impaired global systolic left ventricular
function, according to the inclusion criteria. Pericardial
effusions were not observed.
Hemodynamic measurements
Left ventricular ejection fraction (EF) was 63.5[16]%, left
ventricular enddiastolic pressure (LVEDP) 74 mmHg, pul-
monary capillary wedge pressure (PCWP) 66 mmHg; car-
diac output (CO) 5.652 l/min and cardiac index (CI) 31
(l/min/m2).
Myocardial biopsies
Myocardial inflammation or endothelial activation was
confirmed by immunohistology in myocardial biopsies in
30/38 patients, according to the criteria described above.
In 8/38 patients no inflammatory immune response was
detected. In 23/38 patients, myocardial virus persistence
was demonstrated in myocardial biopsies, 15/38 had no
myocardial virus persistence. Endothelial activation
(sumscore) was 64, leukocyte counts were 0.8 [1.2] CD2+,
0.8 [1.1] CD3+, 0.3 [0.5] CD4+, 0.3 [0.4] CD8+, 0.8 [1.3]
CD45RO and 0.95 [1.2] macrophages. Myocyte necrosis
were not observed in this study population.
Cytokine measurements
Serum concentration for sIL-4 was 37.65 [39.57], for IFN-
g 4.75 [4.5], for IFN-b 34.90 [25.4], for IFN-a 1.55 [1.57],
for sIL-12p7 8.31 [9.64] and for TNF-a 7.09 [11.67] pg/
ml.
Serum concentrations of TNFa correlated significantly
with myocardial CD3+ lymphocytes (r = -0.382, p =
0.020), no correlations were observed between TNFa and
other myocardial leukocytes or other cytokines and myo-
cardial leukocytes. No correlation was observed between
cytokine concentrations and endothelial activation. Con-
centrations of IFNg correlated significantly with PCWP (p
= 0.001, r = 0.571), no correlations were observed
between the other cytokines and hemodynamic parame-
ters. Concentrations of IFNb and IFNa were inversely cor-
related (p = 0.041, r = -0.333), no correlations were
observed between the other cytokines.
CRP-levels were below 6 mg/l and white cell counts were
normal in the study population.
Endothelial function
General Characteristics
Heart rate and blood-pressure (systolic and diastolic) did
not change significantly during measurements with reac-
tive hyperemia and after application of glyceroltrinitrate.
Adequate reactive hyperemia was achieved in all subjects.
Mean resting diameter of the radial artery was 2.34[1] mm
at baseline, after reactive hyperemia the mean diameter
increased to 2.52[1] mm and after glyceroltrinitrate
(GTN) to 2.93[1] mm.
Flow mediated vasodilation
Endothelial function, as determined by FMD of the radial
artery, was impaired in the study population (FMD 4.38
[4.82]%). sIL-12p7 levels were significantly higher in
patients with severely impaired FMD (FMD < 4.00, n =
17), compared with normal or moderately impaired FMD
(FMD >= 4, n = 21): 10.70 [10.72] versus 4.33 [7.81] pg/
ml (p = 0.002) (Fig. 1). FMD correlated significantly with
serum concentrations of sIL-12p7 (p = 0.024, r = -0.365),
but not with sIL-4 (p = 0.360, r = 0.153), IFN-g (p = 0.275,
r = -0.182), IFN-b (p = 0.498, r = -0.113), IFN-a (p = 0.594,
r = -0.089) and TNFa (p = 0.167, r = -0.229) (Fig. 2). FMD
correlated significantly with myocardial CD3+ leukocytes
(p = 0.015, r = -0.398) and CD4+ leukocytes (p = 0.023, r
= -0.374).Cardiovascular Ultrasound 2007, 5:49 http://www.cardiovascularultrasound.com/content/5/1/49
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In the patient subgroup with myocardial inflammation,
similar correlations were observed as for the total study
population, additionally however, we found a significant
correlation between FMD and TNFa (p = 0.017, r = 0.432).
Endothelium independent vasodilation
Endothelium independent vasodilation in response to
GTN was not significantly impaired in the study popula-
tion (GTN-MD 23.67 [8.21]%). No significant correla-
tions were observed between GTN-MD and sIL-4, IFN-g,
IFN-b, IFN-a, sIL-12p7 and TNF-a. GTN-MD correlated
significantly with myocardial CD3+ (p = 0.024, r = -
0.370) and CD45RO leukocytes (p = 0.002, r = -0.487).
Impact of age and hemodynamic parameters
Age, ejection fraction and other hemodynamic measure-
ments did not vary extensively among the study popula-
tion, therefor, therse parameters had no significant impact
on endothelial function or cytokine concentration or
endothelial activation, with the exception of a correlation
between PCWP and IFNg (p = 0.001, r = 0.571).
Discussion
Endothelial dysfunction of peripheral arteries has been
associated with myocardial inflammation and myocardial
virus persistence, even in the absence of severely impaired
left ventricular function [1-3]. The link between periph-
eral endothelial dysfunction and non-ischemic myocar-
dial disease has remained obscure until now. In this study,
we have demonstrated for the first time a relationship
between circulating cytokines and peripheral endothelial
dysfunction in patients with non-ischemic myocardial
disease with preserved or only mildly impaired left ven-
tricular function. Generalized inflammatory immune
responses are known to be associated with peripheral
endothelial dysfunction [4-8]. In this study, we focused
on patients with chronic myocardial disease, so far
thought off to be localized, where significant acute sys-
temic inflammation or acute myocarditis was excluded.
We found, that endothelial dysfunction of peripheral
arteries in patients with non-ischemic heart disease is
associated with elevated sIL-12p7 concentrations in
venous serum. sIL-12p7 activates NK-cells and displays
proinflammatory actions which may potentially result in
endothelial dysfunction. For sIL-4, IFN-g, IFN-b and IFN-
a no association with endothelial dysfunction was
observed. For s-IL-4 this was expected, as it inhibits
cytokine and protease production and therefor may pro-
tect endothelium. IFN-g can display proinflammatory as
well as antiinflammatory properties, which may explain,
that a correlation with endothelial function was observed
for sIL-12p7 but not for IFN-g.
In patients with myocardial inflammation, there was also
a significant correlation between TNFa and endothelial
function, impaired FMD is associated with lower TNFa
concentrations. TNFa activates macrophages, induces
expression of cellular adhesion molecules, and enhances
prostaglandine and metalloproteinase production. It is
elevated in patients with heart failure [20,21], but studies
with the intention to block its actions have not conclu-
sively shown prognostic benefits. In our study population
with only mild or regional LV-dysfunction, TNFa levels
were not markedly elevated. Reduced TNFa concentra-
tions in the presence of myocardial inflammation may
reflect an impaired ability to induce an adequate immune
response, with damage of the endothelium by the inflam-
mation inducing agent.
The association between endothelial function and circu-
lating cytokines in patients with non-ischemic cardiomy-
opathy helps to understand pathomechanisms in
myocardial disease and may explain symptoms. Whether
cytokine production is localized to areas of inflammation
or virus persistence in the heart or if it is due to general-
ized vascular inflammation cannot be differentiated by
this study. Endothelial dysfunction may be induced by cir-
culating cytokines through decreased production or
decreased bioavailability of endothelium derived nitric
oxide.
sIL-12p7 concentrations for patients with severely impaired  endothelial function (FMD < 4.00, n = 17), compared with  normal or moderately impaired endothelial function (FMD  >= 4, n = 21) (p = 0.002) Figure 1
sIL-12p7 concentrations for patients with severely impaired 
endothelial function (FMD < 4.00, n = 17), compared with 
normal or moderately impaired endothelial function (FMD 
>= 4, n = 21) (p = 0.002).
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Endothelial function (FMD) of peripheral arteries in relation to circulating cytokine concentrations: sIL12 (upper left), TNF-a  (lower left), sIL4, IFNg, IFNb and IFNa (right) Figure 2
Endothelial function (FMD) of peripheral arteries in relation to circulating cytokine concentrations: sIL12 (top), TNF-a, sIL4, 
IFNg, IFNb and IFNa (bottom). Significant correlation for FMD and sIL12 (p = 0.024), but not for other cytokines.
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Conclusion
Elevated cytokine sIL-12p7 concentrations in the periph-
eral circulation in patients with non-ischemic heart dis-
ease are associated with systemic endothelial dysfunction.
These circulating cytokines may explain, that in patients
with non-ischemic heart disease endothelial dysfunction
is not restricted to the coronary circulation, but also
involves systemic arteries. This finding is clinically impor-
tant, as endothelial function represents an important pre-
dictor of prognosis [9-12] and may influence therapeutic
decisions.
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